SCARLATO, GUGLIELMO
 Distribuzione geografica
Continente #
EU - Europa 7.190
AS - Asia 5.472
NA - Nord America 5.164
SA - Sud America 482
AF - Africa 157
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.477
Nazione #
US - Stati Uniti d'America 4.886
GB - Regno Unito 3.224
SG - Singapore 1.730
CN - Cina 1.641
RU - Federazione Russa 785
SE - Svezia 751
IT - Italia 665
VN - Vietnam 484
HK - Hong Kong 402
BR - Brasile 374
DE - Germania 346
KR - Corea 341
TR - Turchia 316
FR - Francia 290
NL - Olanda 281
CA - Canada 237
IN - India 233
IE - Irlanda 226
UA - Ucraina 199
FI - Finlandia 188
EU - Europa 132
CI - Costa d'Avorio 105
BD - Bangladesh 90
PL - Polonia 58
GR - Grecia 55
JP - Giappone 52
ID - Indonesia 45
DK - Danimarca 29
AR - Argentina 28
IQ - Iraq 25
BE - Belgio 23
CO - Colombia 23
MX - Messico 17
PK - Pakistan 15
VE - Venezuela 15
EC - Ecuador 11
RO - Romania 11
CH - Svizzera 10
SA - Arabia Saudita 9
ZA - Sudafrica 9
AT - Austria 8
CL - Cile 8
ES - Italia 8
JM - Giamaica 8
KE - Kenya 8
MY - Malesia 8
TH - Thailandia 8
UZ - Uzbekistan 8
BO - Bolivia 7
MA - Marocco 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
AU - Australia 6
IL - Israele 6
OM - Oman 6
PH - Filippine 6
DZ - Algeria 5
EG - Egitto 5
JO - Giordania 5
TN - Tunisia 5
AZ - Azerbaigian 4
BB - Barbados 4
BY - Bielorussia 4
GA - Gabon 4
GT - Guatemala 4
HN - Honduras 4
KW - Kuwait 4
KZ - Kazakistan 4
LB - Libano 4
LT - Lituania 4
NP - Nepal 4
PE - Perù 4
UY - Uruguay 4
LK - Sri Lanka 3
MD - Moldavia 3
NG - Nigeria 3
DO - Repubblica Dominicana 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
IS - Islanda 2
KG - Kirghizistan 2
RS - Serbia 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GY - Guiana 1
KH - Cambogia 1
LU - Lussemburgo 1
MR - Mauritania 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 18.594
Città #
Southend 3.065
Singapore 974
Seattle 490
Chandler 488
Hong Kong 387
Ashburn 353
San Jose 353
Princeton 323
Wilmington 233
Beijing 231
Dublin 226
Milan 225
Council Bluffs 193
Redmond 184
Santa Clara 179
Toronto 174
Los Angeles 140
Nanjing 138
Dallas 133
Lauterbourg 130
Sakarya 130
Des Moines 126
Bengaluru 122
Ho Chi Minh City 115
Mountain View 109
Abidjan 105
Moscow 104
Ann Arbor 100
Boardman 94
Buffalo 90
Hanoi 90
Eitensheim 83
Jinan 78
New York 78
Dearborn 77
Guangzhou 71
Jacksonville 60
Shenyang 60
Athens 54
Woodbridge 52
Cangzhou 49
Warsaw 49
The Dalles 48
Dong Ket 46
Fairfield 43
Shanghai 42
Hebei 41
Tianjin 39
Changsha 38
Columbus 37
Houston 37
Andover 35
Tokyo 35
Ottawa 34
São Paulo 34
Hefei 33
Nanchang 32
Frankfurt am Main 29
Zhengzhou 29
Bitonto 28
Jiaxing 25
Brussels 23
Helsinki 23
Phoenix 23
Berlin 21
Munich 20
Rome 20
San Diego 19
Rio de Janeiro 17
Hangzhou 16
Shenzhen 16
Somerville 16
Serra 15
Bogotá 14
Auburn Hills 13
Belo Horizonte 13
Hanover 13
Mumbai 13
Ningbo 13
Seoul 13
Quanzhou 12
Taiyuan 12
Yubileyny 12
Fuzhou 11
Haiphong 11
Nuremberg 11
Turin 11
Wuhan 11
Dhaka 10
Grafing 10
Taizhou 10
Da Nang 9
Düsseldorf 9
Haikou 8
Montreal 8
Orem 8
Redwood City 8
Tashkent 8
Washington 8
Jakarta 7
Totale 11.715
Nome #
Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block 252
In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells : Evidence of programmed cell death after muscle cell transplantation 223
Central nervous system trans-synaptic effects of acute axonal injury : a 1-H magnetic resonance spectroscopy study 219
1-H magnetic resonance spectroscopy of the guinea-pig optic nerve: undetectable levels of N-acetylaspartate 219
Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells 202
Severe chronic sensory-motor polyneuropathy: coexistence of 3 unrelated etiologies in a type 1 diabetic patient. A case report and review of the literature 197
Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues 192
Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies 187
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease 186
Trans-synaptic degeneration following acute axonal injury. A l-H magnetic resonance spectroscopy study 186
Complex IV change in the mitochondria respiratory chain of chronic external ophtalmoplegia : a review of our cases 184
Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-1beta and p75NTR 181
Bartolomeo Panizza and the discovery of the brain's visual center 181
A sporadic, atypical case of desminopathy: morphological and immunological characterization 180
Diagnostic relevance of anti-neural antibodies in dysimmune neuropathies 179
Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neuron disease 175
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 170
Cytogenetic analysis and muscle differentiation in a girl with severe muscular dystrophy 166
Oculopharyngeal myopathy with partial cytochrome c oxidase deficiency 164
Fatal familial insomnia : genetic, neuropathologic, and biochemical study of a patient from a new Italian kindred 161
Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome 161
Idiopathic inflammatory polyradiculoneuropathy: evaluation of clinical and laboratory data and therapeutic considerations 160
Incidence of peripheral neuropathy and of anti-MAG antibodies in patients with IgM monoclonal gammopathy 159
Neuroimmunologia del sistema nervoso periferico 157
Guillain-Barré syndrome : an Italian multicentre case-control study 157
Peripheral neuropathy and IgM paraproteins: an immunopathogenetic study 156
Cytochrome c oxidase during human fetal development 156
Neuropatia in corso di gammopatia monoclonale IgM : specificita' antigenica delle paraproteine 155
Multifocal motor neuropathy and Campylobacter jejuni reactivity 154
Anti-sulfatide IgM antibodies in peripheral neuropathy 154
A new antigen specificity of the M-protein in a patient with neuropathy and macroglobulinemia 153
Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins 152
Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies 151
Anti-GM1 IgM antibodies in motor neuron disease and neuropathy 150
Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins 149
Visual evoked potentials in patients with neuropathy and macroglobulinemia 148
VEPs studies in patients with peripheral neuropaty and macroglobulinemia 148
Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice 147
Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility 147
Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy 145
Antecedent infections in Guillain Barré syndrome (GBS) in northern Italy: a clinical and serological case-control study 145
Abnormal expression of cyclin-dependent kinase in an atypical case of desminopathy 144
Gangliosides. Their role in clinical neurology 141
Multifocal motor neuropathy: clinical and immunological features and response to IVIg therapy in patients with definite, probable or no overt conduction block 141
Peripheral neuropathy and anti-MAG IgM M-proteins: clinical morphological and immunological findings 140
Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia 139
Anti-campylobacter jejuni lipopolysaccharide reactivity in multifocal motor neuropathy 139
Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathies 138
Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins 138
Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies 137
Criteria for early detection of conduction block in multifocal motor neuropathy (MMN): a study based on control populations and follow-up of MMN patients 137
Serum anti-neurofilament antibodies in Alzheimer's disease 135
Differentiation of human adult and fetal muscle after enzymic dissocation 134
A case control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in GBS: correlation with antecedent event and with clinical features 133
Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication 133
Anti-myelin-associated glycoprotein antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy 133
Studies on anti-myelin antibodies in patients with multiple sclerosis 133
Is campylobacter jejuni enteritis a risk factor for Guillain Barré sindrome in Italy? A case control study by western blot in northern Italy 131
Failure to detect anti-MAG antibodies by RIA in CSF of patients with multiple sclerosis 130
Anti-MAG antibodies and antibody complexes in patients with peripheral neuropathy and IgM M-protein 130
Chronic progressive external ophthalmoplegia: A correlative study of quantitative molecular data and histochemical and biochemical profile 130
Serum IgG antibodies to a 35-kDa P0-related glycoprotein in motor neuron disease 129
Effect of high-dose intravenous immunoglobulin (IVIg) on anti-glycolipid reactivity in multifocal motor neuropathy (MMN) 128
Anti-GD1a ganglioside antibodies in peripheral motor syndromes 127
Anti-ganglioside and anti-Campylobacter Jejuni (CJ) antibodies in Guillain-Barré syndrome (GBS): regional and temporal variability in Italian patients 127
Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies 126
Clinical relevance of anti-GM1 IgM antibodies 126
Expression of glycosylated recombinant human myelin-associated glycoprotein on a neuroblastoma cell line and its reactivity with HNK-1 but not human anti-MAG antibodies 126
Multifocal motor neuropathy and campylobacter jejuni reactivity 126
Anti-MAG antibodies in CSF of patients with multiple sclerosis : study by RIA 126
Serum antibodies to campylobacter jejuni in multifocal motor neuropathy 125
IgM reactivity with a human neuroblastoma cell line in patients with peripheral neurological disorders 125
Effect of high-dose intravenous immunoglobulin (IVIg) on anti-glycolipid reactivity in multifocal motor nuropathy (MMN) 124
Long-term effect of IVIg in multifocal motor neuropathy 123
Predictive value of anti-GM1 IgM and IgG antibodies for dysimmune neuropathies 123
An atypical case of desminopathy with abnormal expression of cyclin-dependent kinase 123
Treatment of patients with neuropathy and anti-MAG IgM M-proteins 121
Long-term effect of intravenous immunoglobulin therapy (IVIg) in multifocal motor neuropathy (MMN) 121
Anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain Barré syndrome: A case control study 121
Morphologic and metabolic studies in a case of oculo-cranio-somatic neuromuscular disease 121
Clinical and immunological study in neuropathy associated with IgG MGUS 120
Small fibre involvement in neuropathy associated with IgG, IgA and IgM monoclonal gammopathy 119
Pain: a frequent and often overlooked presenting symptom in Guillain Barré syndrome 119
Antigen expression by cultured human Schwann cells 118
The neuroblastoma cell line SK-N-SH is an ideal cellular model for expression of human MAG cDNA and the strudy of anti-MAG peripheral neuropathies 117
Anti-GD1a antibodies in motor neuropathies 117
Anti-GM1 antibodies in multifocal motor neuropathy : effect of intravenous immunoglobulin therapy 117
Deterioration of multifocal motor neuropathy after plasma exchange 116
The significance of monoclonal gammopathy in motor neuron disease and related syndromes 116
IgM reactivitry with a human neuroblsatoma cell line in patients with peripheral neurological disorders 116
Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome 115
Proximal myotonic myopathy (PROMM) syndrome without CTG expansion: a new case 114
Motor Neurones in culture as a model to study ALS 112
Antigen specificity of the M-protein in 77 patients with neuropathy and IgM monoclonal gammopathy 112
Multiple deletions of mitochondrial DNA in a patient with periodic attacks of paralysis 112
Risk factors for Guillain Barré sindrome (GBS) in northern Italy: analysis of anamnestic antecedent events and serological evidence of infections 110
Clinical and immunological features and response to IVIg in patients with clinically typical multifocal motor neuropathy but no overt conduction block 109
Anti-GM1 antibodies in CSF of Guillain Barre' Syndrome and motor neuropathy 107
Anti-GM1 IgM antibodies in motor neuron disase and other neurological diseases 107
Long term effect of IVIg and oral CTX in multifocal motor neuropathy (MMN) 106
Totale 14.371
Categoria #
all - tutte 51.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 0 0 203
2021/20221.356 102 29 25 48 101 198 52 30 206 132 123 310
2022/20231.589 214 129 178 197 206 338 20 77 142 18 54 16
2023/2024905 29 89 36 17 210 28 50 48 17 107 116 158
2024/20252.615 93 166 50 214 418 83 70 305 139 279 193 605
2025/20264.486 313 162 436 435 506 413 610 343 590 405 166 107
Totale 19.743